Fagron Compounding Services Tropicamide 1%/Cyclopentolate 1%/Phenylephrine recall: Incorrect Product Formulation
Incorrect Product Formulation
The hazard: Sterility or particulate concern
The concern here is contamination of a product that bypasses the body’s normal defences, which is why the threshold for recalling it is low.
What the notice says: Incorrect Product Formulation
Why it matters: The product was made or packaged in conditions that cannot assure sterility, or visible particles were found in it. For anything injected, infused or used in the eye, that is a direct route for contamination into the body.
Symptoms and when to call a doctor
Watch for fever, chills, pain, redness, swelling or discharge at an injection site, and for a red, painful or suddenly blurred eye after using an eye product. Any of these needs same-day medical attention. Do not wait to see whether it settles, and tell the clinician which product and lot you used so it can be reported against the recall.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0221-2026
- Published
- December 17, 2025
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Fagron Compounding Services
- Product type
- Prescription & OTC drugs
- Units affected
- 2980 syringes
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Lot#: C274-000047958; Exp. December 19, 2025
Products covered by this recall
Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic Solution, 0.5mL Single-Use Syringe, For Topical Ophthalmic Use Only. Not for IV Use. Fagron Sterile Services, 8710 E 34th St N, Wichita, KS 67226. NDC: 71266-8240-01
Check your product
The notice names 5 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- C274-000047958
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- December 19
- 2025 — 2980 syringes
NDC number
On the carton and again on the bottle or blister label.
- 71266-8240-01
Package size
Match the net weight or the piece count on the front of the pack.
- 0.5 mL
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Sterility
Fagron Compounding Services — The concern here is contamination of a product that bypasses the body’s normal defences, which is why the threshold for recalling it is low.
- Stop using the affected lot and check the lot number on your own carton or vial against the codes listed above.
- Call your prescriber or pharmacy today about a replacement from an unaffected lot — do not simply skip doses of a medicine you depend on.
- If you are a clinic or pharmacy, quarantine the stock and work it through your usual recall log.
- Report any infection or reaction you think the product caused to FDA MedWatch.
Getting a replacement supply
Do not let a refund question interrupt your treatment. Deal with the supply first and the money second.
- Call the pharmacy before you run low. They can see which lot they dispensed to you and will usually swap it the same day.
- Insurers do not normally count a recall replacement against a refill limit. If one is refused, ask the pharmacist to call it through as a recall override.
- Over-the-counter products are refunded at the till like any other purchase; the recall notice on your phone is enough to explain the return.
- If the manufacturer runs a direct reimbursement form, it will be linked from the official notice on this page.
Company contact: Fagron Compounding Services — 8710 E 34th St N, Wichita, KS, 67226-2636
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Fagron Compounding Services prescription & otc drugs recalled?
Incorrect Product Formulation Incorrect Product Formulation
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code C274-000047958; best-by date December 19 or 2025 — 2980 syringes. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Stop using the affected lot and check the lot number on your own carton or vial against the codes listed above.
Can I get my money back?
Call the pharmacy before you run low. They can see which lot they dispensed to you and will usually swap it the same day.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 6 months ago
Fagron Compounding Services Vancomycin HCI, 1.5 grams added to 250 mL recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
-
Class II · 6 months ago
Fagron Compounding Services Vancomycin HCI, 1.25 grams added to 250 mL recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
-
Class II · 6 months ago
Fagron Compounding Services norepinephrine Bitartrate recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
-
Class II · 6 months ago
Fagron Compounding Services norepinephrine Bitartrate recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
-
Class II · 6 months ago
Fagron Compounding Services Vancomycin HCL, 1 gram added to 250 mL recall: Lack of Assurance of Sterility; blue Break-Off-Part could detach
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
-
Class II · 1+ years ago
Fagron Compounding Services bevacizumab Injection, 1.25mg/0.05mL recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility